| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | B Wilhelm | |
| T Kunt | |||
| M M Weber | |||
| T Forst | |||
| A Pfützner | |||
| P2860 | cites work | Defining of the minimal domain of protein 4.1 involved in spectrin-actin binding | Q28297356 |
| Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor | Q28299224 | ||
| Effects of hyperglycaemia and sorbitol accumulation on erythrocyte deformability in diabetes mellitus | Q28360721 | ||
| Proinsulin C-peptide activates cAMP response element-binding proteins through the p38 mitogen-activated protein kinase pathway in mouse lung capillary endothelial cells | Q28513872 | ||
| The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine | Q29547539 | ||
| The effect of human proinsulin C-peptide on erythrocyte deformability in patients with Type I diabetes mellitus | Q30681476 | ||
| Effects of proinsulin C-peptide on nitric oxide, microvascular blood flow and erythrocyte Na+,K+-ATPase activity in diabetes mellitus type I. | Q30839539 | ||
| Diabetes and endothelial dysfunction: a clinical perspective | Q31835799 | ||
| Skin microcirculation in patients with type I diabetes with and without neuropathy after neurovascular stimulation | Q32061773 | ||
| Biological activity of C-peptide on the skin microcirculation in patients with insulin-dependent diabetes mellitus | Q32063285 | ||
| Impact of insulin on microvascular blood flow and endothelial cell function in the postprandial state in patients with Type 1 diabetes | Q33214613 | ||
| C-peptide does not affect ocular blood flow in patients with type 1 diabetes | Q33255497 | ||
| Beneficial effects of C-peptide on incipient nephropathy and neuropathy in patients with Type 1 diabetes mellitus | Q33899769 | ||
| Red cell deformability and its relevance to blood flow | Q34183477 | ||
| Does combined kidney and pancreas transplantation reverse functional diabetic microangiopathy? | Q34308303 | ||
| Prevention of vascular and neural dysfunction in diabetic rats by C-peptide. | Q34433058 | ||
| Basal phosphatidylinositol turnover controls aortic Na+/K+ ATPase activity | Q34521084 | ||
| Modulation of erythrocyte membrane material properties by Ca2+ and calmodulin. Implications for their role in regulation of skeletal protein interactions | Q34558832 | ||
| Endothelium-dependent relaxation to acetylcholine in the rabbit basilar artery: importance of membrane hyperpolarization. | Q35870564 | ||
| Aetiology of Diabetic Foot Ulceration: A Role for the Microcirculation? | Q36188679 | ||
| Skin microvascular autoregulatory responses in type I diabetes: the influence of duration and control | Q36418416 | ||
| A new erythrocyte membrane-associated protein with calmodulin binding activity. Identification and purification | Q36461806 | ||
| Specific binding of proinsulin C-peptide to human cell membranes | Q36671827 | ||
| Skin capillary circulation is more impaired in the toes of diabetic than non-diabetic patients with peripheral vascular disease | Q36699757 | ||
| Skin capillary circulation severely impaired in toes of patients with IDDM, with and without late diabetic complications | Q36709563 | ||
| Calmodulin-dependent endothelium-derived relaxing factor/nitric oxide synthase activity is present in the particulate and cytosolic fractions of bovine aortic endothelial cells | Q37416665 | ||
| Is hyperviscosity a treatable component of diabetic microcirculatory disease? | Q39455422 | ||
| A review of the development of large-vessel disease in diabetes mellitus | Q39543842 | ||
| Biochemical characterization of density-separated human erythrocytes | Q39757227 | ||
| Microvascular function in human diabetes. A physiological perspective | Q40550044 | ||
| Understanding the sodium pump and its relevance to disease. | Q40694402 | ||
| Effects of C-peptide on blood flow, capillary diffusion capacity and glucose utilization in the exercising forearm of type 1 (insulin-dependent) diabetic patients | Q41846960 | ||
| Effects of C-peptide on forearm blood flow and brachial artery dilatation in patients with type 1 diabetes mellitus | Q43687338 | ||
| Beta-cell function and the development of diabetes-related complications in the diabetes control and complications trial | Q44333576 | ||
| Effects of proinsulin C-peptide in experimental diabetic neuropathy: vascular actions and modulation by nitric oxide synthase inhibition | Q44493437 | ||
| Stimulation of endothelial nitric oxide synthase by proinsulin C-peptide | Q44659085 | ||
| Association of diabetic neuropathy with Na/K ATPase gene polymorphism. | Q50954039 | ||
| Postprandial myocardial perfusion in healthy subjects and in type 2 diabetic patients. | Q51514389 | ||
| Reduction of erythrocyte (Na+-K+)ATPase activity in type 1 (insulin-dependent) diabetic subjects and its activation by homologous plasma. | Q51632933 | ||
| Higher Levels of Erythrocyte Membrane Microviscosity in Diabetes | Q51661042 | ||
| Responses of the skin microcirculation to acetylcholine and sodium nitroprusside in patients with NIDDM. | Q53974777 | ||
| Impaired contraction and endothelium-dependent relaxation in isolated resistance vessels from patients with insulin-dependent diabetes mellitus. | Q54199822 | ||
| Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. | Q54225577 | ||
| Reduced erythrocyte deformability in diabetes | Q67377700 | ||
| Red-cell aggregation and red-cell deformability in diabetes | Q67826274 | ||
| Altered cellular Ca2+ and Na+ transport in diabetes mellitus | Q68463918 | ||
| Increased sodium influx into erythrocytes in diabetes mellitus and hypertension | Q68965640 | ||
| Selective attenuation of endothelium-mediated vasodilation in atherosclerotic human coronary arteries | Q69015514 | ||
| Myogenic activity in isolated subepicardial and subendocardial coronary arterioles | Q69048897 | ||
| Altered red and white blood cell rheology in type II diabetes | Q69640971 | ||
| Effects of Na+,K+-pump inhibitors and membrane depolarizing agents on acetylcholine-induced endothelium-dependent relaxation and cyclic GMP accumulation in rat aorta | Q70082850 | ||
| Venous oxygenation in the diabetic neuropathic foot: evidence of arteriovenous shunting? | Q70285938 | ||
| Renal tubular Na(+)-K(+)-ATPase in diabetes mellitus: relationship to metabolic abnormality | Q70467171 | ||
| C-peptide stimulates rat renal tubular Na+, K(+)-ATPase activity in synergism with neuropeptide Y | Q71090510 | ||
| Activation of the sodium-potassium pump contributes to insulin-induced vasodilation in humans | Q71506852 | ||
| Acute effects of C-peptide on the microvasculature of isolated perfused skeletal muscles and kidneys in rat | Q71675242 | ||
| Early reduction of vascular reactivity in diabetic children detected by transcutaneous oxygen electrode | Q72471862 | ||
| Stimulation of vascular Na(+)-K(+)-ATPase activity by nitric oxide: a cGMP-independent effect | Q72679881 | ||
| Alteration of Na,K-ATPase isoenzymes in diabetic cardiomyopathy: effect of dietary supplementation with fish oil (n-3 fatty acids) in rats | Q73370568 | ||
| Reversal by L-arginine of a dysfunctional arginine/nitric oxide pathway in the endothelium of the genetic diabetic BB rat | Q73617177 | ||
| The effects ex vivo and in vitro of insulin and C-peptide on Na/K adenosine triphosphatase activity in red blood cell membranes of type 1 diabetic patients | Q74052096 | ||
| Differential effects of proinsulin C-peptide fragments on Na+, K+-ATPase activity of renal tubule segments | Q74440925 | ||
| The influence of advanced glycation endproducts (AGE) on the expression of human endothelial adhesion molecules | Q77115790 | ||
| C-peptide induces a concentration-dependent dilation of skeletal muscle arterioles only in presence of insulin | Q77312861 | ||
| C-Peptide reverses nociceptive neuropathy in type 1 diabetes | Q79386801 | ||
| Endothelial function in patients with type 1 diabetes evaluated by skin capillary recruitment | Q79664384 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | peptide | Q172847 |
| hormone | Q11364 | ||
| C-peptide | Q419107 | ||
| microvessel | Q6840468 | ||
| P304 | page(s) | 176245 | |
| P577 | publication date | 2008-01-01 | |
| P1433 | published in | Experimental Diabetes Research | Q26842719 |
| P1476 | title | Role of C-Peptide in the regulation of microvascular blood flow | |
| P478 | volume | 2008 |
| Q36365226 | C-Peptide and vascular complications in type 2 diabetic subjects |
| Q38006686 | C-peptide: a new mediator of atherosclerosis in diabetes |
| Q36365246 | Correlations between Glucagon Stimulated C-peptide Levels and Microvascular Complications in Type 2 Diabetes Patients |
| Q35046125 | Effects of panax quinquefolium on streptozotocin-induced diabetic rats: role of C-peptide, nitric oxide and oxidative stress. |
| Q92500957 | Pancreatic Blood Flow with Special Emphasis on Blood Perfusion of the Islets of Langerhans |
| Q64092653 | Partial Clinical Remission of Type 1 Diabetes Mellitus in Children: Clinical Applications and Challenges with its Definitions |
| Q38023858 | Proinflammatory effects of C-Peptide in different tissues |
| Q33917570 | The renal vascular response to diabetes |
Search more.